Addus HomeCare Co. (NASDAQ:ADUS – Get Free Report) CEO R Dirk Allison sold 25,000 shares of the firm’s stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total transaction of $3,119,000.00. Following the sale, the chief executive officer now directly owns 79,397 shares of the company’s stock, valued at approximately $9,905,569.72. The trade was a 23.95 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink.
R Dirk Allison also recently made the following trade(s):
- On Monday, November 25th, R Dirk Allison sold 12,500 shares of Addus HomeCare stock. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00.
Addus HomeCare Stock Performance
Shares of ADUS stock opened at $124.59 on Monday. Addus HomeCare Co. has a 52-week low of $85.94 and a 52-week high of $136.12. The stock has a market cap of $2.26 billion, a PE ratio of 28.51, a PEG ratio of 2.11 and a beta of 1.00. The firm’s 50 day moving average price is $125.12 and its two-hundred day moving average price is $125.83.
Institutional Investors Weigh In On Addus HomeCare
Several institutional investors have recently added to or reduced their stakes in the stock. Quarry LP acquired a new stake in Addus HomeCare in the 3rd quarter valued at $28,000. Quest Partners LLC acquired a new stake in Addus HomeCare in the 2nd quarter valued at $31,000. Farther Finance Advisors LLC increased its stake in Addus HomeCare by 9,150.0% in the 3rd quarter. Farther Finance Advisors LLC now owns 370 shares of the company’s stock valued at $49,000 after buying an additional 366 shares during the last quarter. Sandia Investment Management LP acquired a new stake in Addus HomeCare in the 2nd quarter valued at $58,000. Finally, GAMMA Investing LLC increased its stake in Addus HomeCare by 25.7% in the 3rd quarter. GAMMA Investing LLC now owns 935 shares of the company’s stock valued at $124,000 after buying an additional 191 shares during the last quarter. 95.35% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several analysts have recently weighed in on ADUS shares. Citizens Jmp raised shares of Addus HomeCare to a “strong-buy” rating in a report on Monday, December 16th. Oppenheimer raised their price target on shares of Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Stephens raised their price target on shares of Addus HomeCare from $143.00 to $145.00 and gave the company an “overweight” rating in a report on Wednesday, November 6th. JMP Securities started coverage on shares of Addus HomeCare in a report on Monday, December 16th. They issued an “outperform” rating and a $150.00 price target for the company. Finally, StockNews.com raised shares of Addus HomeCare from a “hold” rating to a “buy” rating in a report on Wednesday, December 11th. One research analyst has rated the stock with a sell rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Buy” and an average target price of $133.67.
Check Out Our Latest Research Report on Addus HomeCare
About Addus HomeCare
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Stories
- Five stocks we like better than Addus HomeCare
- Why Are These Companies Considered Blue Chips?
- Cold Front, Hot Stocks: Diesel Prices Propel Energy Leaders
- 3 Tickers Leading a Meme Stock Revival
- Sustainable and Successful: 3 Climate ETFs Beating the Market
- What Are Dividend Contenders? Investing in Dividend Contenders
- Quantum Opportunity: Skywater Technology’s Long-Term Potential
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.